Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.

Chen YF, Jowett S, Barton P, Malottki K, Hyde C, Gibbs JS, Pepke-Zaba J, Fry-Smith A, Roberts J, Moore D.

Health Technol Assess. 2009 Oct;13(49):1-320. doi: 10.3310/hta13490. Review.

2.

Inhaled iloprost for severe pulmonary hypertension.

Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W; Aerosolized Iloprost Randomized Study Group.

N Engl J Med. 2002 Aug 1;347(5):322-9.

3.

Inhaled iloprost for the control of acute pulmonary hypertension in children: a systematic review.

Mulligan C, Beghetti M.

Pediatr Crit Care Med. 2012 Jul;13(4):472-80. doi: 10.1097/PCC.0b013e31822f192b. Review.

PMID:
21926655
4.
5.

Inhaled low-dose iloprost for pulmonary hypertension: a prospective, multicenter, open-label study.

Sun YJ, Xiong CM, Shan GL, Gu Q, Zeng WJ, Lu XL, Zhu F, Liu ZH, Ni XH, He JG; Iloprost Therapy on Pulmonary Hypertension Study Group.

Clin Cardiol. 2012 Jun;35(6):365-70. doi: 10.1002/clc.21987. Epub 2012 Apr 9.

PMID:
22488211
6.

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.

Knudsen L, Schurawlew A, Nickel N, Tiede H, Ghofrani HA, Wilkens H, Ewert R, Halank M, Klose H, Bäzner C, Behr J, Hoeper MM.

BMC Pulm Med. 2011 Dec 1;11:56. doi: 10.1186/1471-2466-11-56.

7.

No additive effects of inhaled iloprost and prone positioning on pulmonary hypertension and oxygenation in acute respiratory distress syndrome.

Senturk E, Cakar N, Ozcan PE, Basel A, Sengul T, Telci L, Esen F, Nahum A, Strang CM, Winterhalter M.

Minerva Anestesiol. 2012 Sep;78(9):1005-12. Epub 2012 Apr 4.

8.

Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension.

Gürakan B, Kayiran P, Oztürk N, Kayiran SM, Dindar A.

Pediatr Pulmonol. 2011 Jun;46(6):617-20. doi: 10.1002/ppul.21415. Epub 2011 Mar 24.

PMID:
21438177
9.

Acute effects of aerosolized iloprost in COPD related pulmonary hypertension - a randomized controlled crossover trial.

Boeck L, Tamm M, Grendelmeier P, Stolz D.

PLoS One. 2012;7(12):e52248. doi: 10.1371/journal.pone.0052248. Epub 2012 Dec 27.

10.

Relation of bosentan, iloprost, and sildenafil with growth factor levels in monocrotaline-induced pulmonary hypertension.

Yigitaslan S, Sirmagul B.

Clin Exp Hypertens. 2012;34(3):222-9. doi: 10.3109/10641963.2011.631652. Epub 2012 Apr 2.

PMID:
22468718
11.

Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery.

Loukanov T, Bucsenez D, Springer W, Sebening C, Rauch H, Roesch E, Karck M, Gorenflo M.

Clin Res Cardiol. 2011 Jul;100(7):595-602. doi: 10.1007/s00392-011-0284-5. Epub 2011 Feb 13.

PMID:
21318559
12.

Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.

Bourge RC, Tapson VF, Safdar Z, Benza RL, Channick RN, Rosenzweig EB, Shapiro S, White RJ, McSwain CS, Gotzkowsky SK, Nelsen AC, Rubin LJ.

Cardiovasc Ther. 2013 Feb;31(1):38-44. doi: 10.1111/1755-5922.12008.

13.

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F.

Ann Intern Med. 2002 Apr 2;136(7):515-22.

PMID:
11926786
14.

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.

McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ.

Am J Respir Crit Care Med. 2006 Dec 1;174(11):1257-63. Epub 2006 Aug 31.

PMID:
16946127
15.

Inhaled iloprost for patients with precapillary pulmonary hypertension and right-side heart failure.

Martischnig AM, Tichy A, Nikfardjam M, Heinz G, Lang IM, Bonderman D.

J Card Fail. 2011 Oct;17(10):813-8. doi: 10.1016/j.cardfail.2011.05.012. Epub 2011 Jul 8.

16.

Inhaled iloprost as a rescue therapy for transposition of the great arteries with persistent pulmonary hypertension of the newborn.

Avila-Alvarez A, Bravo-Laguna MC, Bronte LD, Del Cerro MJ.

Pediatr Cardiol. 2013;34(8):2027-9. doi: 10.1007/s00246-012-0575-2. Epub 2012 Nov 11.

PMID:
23143352
17.

Acute responses to inhalation of Iloprost in patients with pulmonary hypertension.

Zhang HL, Liu ZH, Wang Y, Xiong CM, Ni XH, He JG, Luo Q, Zhao ZH, Zhao Q, Sun XG.

Chin Med J (Engl). 2012 Aug;125(16):2826-31.

PMID:
22932074
18.

Long-term inhaled iloprost use in children with pulmonary arterial hypertension.

Alehan D, Yıldırım I, Sahin M, Ozkutlu S, Ozer S, Karagöz T.

Cardiol Young. 2012 Aug;22(4):396-403. doi: 10.1017/S1047951111001843. Epub 2011 Nov 9.

PMID:
22067137
19.

Long-term therapy with inhaled iloprost in patients with pulmonary hypertension.

Olschewski H, Hoeper MM, Behr J, Ewert R, Meyer A, Borst MM, Winkler J, Pfeifer M, Wilkens H, Ghofrani HA, Nikkho S, Seeger W.

Respir Med. 2010 May;104(5):731-40. doi: 10.1016/j.rmed.2010.01.008. Epub 2010 Feb 11.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk